Skip to main content
Caplight Logo









Galventa AG

Galventa AG

Private
SwitzerlandHealthcare & Life Scienceshttps://www.galventa.com/

Last Round

Seed

Dec 31, 2023

Est. Valuation

$11.89M

Total Funding Raised

$2.75M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Galventa AG is a life science company that develops patented galenic formulations and nutraceutical products designed to align with circadian rhythms and improve sleep-wake cycles.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Sports & Fitness, Home & Lifestyle

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

nutraceuticalsgalenic technologycircadian rhythmsleep supplementbioavailabilitytime-controlled releasedrug deliverynootropicsDTC supplementstechnology licensingsleep aidactive pharmaceutical ingredientsAPIenergy supplementbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Galventa AG Comparables

Compare Galventa AG with similar companies based on industry and business-model similarity.

Galventa AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nutracode LLC
79%
Zest Labs Inc.
77%
Arise Labs
77%

Galventa AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 31, 2023
GrantJan 28, 2022
Pre SeedOct 4, 2021
AcceleratorMay 21, 2021

Key People

Founding team and executive leadership

Fırat Yerlikaya

Co-Founder & Chief Technology Officer (CTO)

Founding Team

Galventa AG Investors

Notable investors and investment history

Galventa AG investors
InvestorRounds
Founders FactoryPre Seed, Accelerator
Venture KickGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 330% MoM, reaching 2.3K.

  • Apr 6, 2026

    Monthly visitors increased 67% MoM.

Galventa AG Filings

Explore SEC and related filing metadata, where available.

Galventa AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Galventa AG's valuation, stock price, and market status.

Is Galventa AG a public or private company?

Galventa AG is a private company.

What is the current stock price of Galventa AG?

Galventa AG is a private company with no public stock price. Caplight tracks Galventa AG's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Galventa AG worth (valuation)?

Galventa AG's valuation is estimated at $11.9M based on funding round data.

Can I buy Galventa AG stock?

Galventa AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Galventa AG's last funding round?

Galventa AG's most recent funding round was Seed on December 31, 2023.

Who are the main investors in Galventa AG?

Key investors in Galventa AG include Founders Factory, Venture Kick.

Will Galventa AG IPO soon?

No public IPO plans have been announced for Galventa AG.

How can I track Galventa AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Galventa AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSwitzerland
Employee Range4
Year Founded2018
Last FundingDec 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?